Table 1.
Selected clinical features of study patients.
| CLINICAL FEATURES | GA control (N=9) | MPE (N=10) | SPE (N=9) | FGR (N=9) | p-value |
|---|---|---|---|---|---|
| Gestational age at delivery (average in weeks ± SD) | 31.1±5.1 | 32.1±4.8 | 30.9±4.7 | 31.3±5.3 | 0.95 |
| Premature rupture of membranes | 4 | 0 | 0 | 1 | 0.02 |
| Abnormal cardiotocographic findings | 1 | 5 | 5 | 2 | 0.14 |
| Perinatal (fetal) mortality | 0 | 1 | 0 | 1 | 1.00 |
| Cesarean section | 3 | 6 | 5 | 1 | 0.15 |
| Antepartum hemorrhage | 0 | 3 | 1 | 0 | 0.16 |
| Meconium-stained amniotic fluid | 1 | 2 | 2 | 0 | 0.72 |
| Induction of labor | 0 | 2 | 1 | 1 | 0.89 |
| Multiple fetuses | 0 | 2 | 1 | 0 | 0.59 |
Fisher’s exact test indicated that premature rupture of the membranes between the different placenta groups was statistically different (p=0.02). The other clinical features did not differ significantly among the groups.